杜 威廷

Medicine & Life Sciences

1. Epidermolysis Bullosa 100%
2. Whole Exome Sequencing 82%
3. Dermatofibrosarcoma 50%
4. Malassezia 49%
5. Folliculitis 49%
6. Urticaria 40%
7. Multiplex Polymerase Chain Reaction 38%
8. Molecular Pathology 27%
9. Meta-Analysis 25%
10. Staining and Labeling 22%
11. Junctional Epidermolysis Bullosa 20%
12. Mutation 19%
13. Epidermolysis Bullosa Dystrophica 18%
14. Skin 17%
15. Epidermolysis Bullosa Pruriginosa 13%
16. Non-Sedating Histamine H1 Antagonists 13%
17. Omalizumab 12%
18. Physicians 10%
19. fibrin fragment D 10%
20. Genes 9%
21. Dermatologists 9%
22. Epidermolysis Bullosa Simplex 9%
23. Therapeutics 8%
24. Patient Care 8%
25. Clinical Pathology 8%
26. Cyclosporine 8%
27. Margins of Excision 8%
28. Drug Repositioning 7%
29. Hallux 7%
30. Gene Editing 7%
31. Transmission Electron Microscopy 7%
32. Reverse Transcriptase Polymerase Chain Reaction 7%
33. Pregnant Women 7%
34. Antifungal Agents 6%
35. Economics 6%
36. Skin Diseases 6%
37. Routine Diagnostic Tests 6%
38. Translational Medical Research 6%
39. Acne Vulgaris 6%
40. Inborn Genetic Diseases 6%
41. Blister 6%
42. Virulence 6%